首页> 外文期刊>Case Reports in Oncology >Successful Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization followed by Radical Liver Transplantation in a Patient with Severe Liver Damage
【24h】

Successful Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization followed by Radical Liver Transplantation in a Patient with Severe Liver Damage

机译:经肝动脉严重栓塞治疗并经肝动脉根治性肝移植成功治疗肝细胞癌

获取原文
           

摘要

Introduction: Liver transplantation for hepatocellular carcinoma (HCC) has been established as a curative therapy of underlying liver disease and cancer. However, the role of liver transplantation remains controversial for patients with HCC beyond Milan criteria. Case Presentation: A man in his 50s who was diagnosed as having two foci of HCC and advanced liver cirrhosis was referred to our hospital for further examination and treatment. Both foci of HCC were located in segment 8 of the liver and measured 39 and 9 mm. Endoscopy showed esophageal varices that had a high risk of bleeding. After endoscopic ligation of the esophageal varices, he underwent transcatheter arterial chemoembolization (TACE) for downstaging of the advanced HCCs. No further liver deterioration was observed after TACE, and HCC staging was successfully downstaged to within the Milan criteria. One hundred ten days after TACE, he underwent liver transplantation; at 2.5 years after transplantation, he remains alive without HCC recurrence. Discussion/Conclusion: There are only a few treatment options available for patients with advanced HCC and severe liver damage. Multidisciplinary treatment such as locoregional treatments and prophylaxis of variceal bleeding may result in tumor downstaging, enabling radical liver transplantation without further exacerbation of liver damage.
机译:简介:肝细胞癌(HCC)的肝移植已被确立为潜在肝病和癌症的治疗方法。但是,对于米兰标准以外的肝癌患者,肝移植的作用仍存在争议。病例介绍:50多岁的一名男子被诊断出患有两个肝癌灶和晚期肝硬化,被转介到我院进一步检查和治疗。肝癌的两个病灶均位于肝脏的第8段,分别为39和9 mm。内窥镜检查显示食管静脉曲张有很高的出血风险。内镜下结扎食管静脉曲张后,他进行了经导管动脉化疗栓塞(TACE),以降低晚期肝癌的分期。 TACE后未观察到肝进一步恶化,并且HCC分期成功降低至米兰标准之内。 TACE治疗后一百十一天,他接受了肝移植。移植后2.5年,他仍然存活,没有HCC复发。讨论/结论:对于晚期HCC和严重肝损伤的患者,只有几种治疗选择。多学科治疗(例如局部治疗和预防静脉曲张破裂出血)可能会导致肿瘤分期降低,从而能够进行根本性肝移植,而不会进一步加剧肝损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号